Menu
GeneBe

RP2

RP2 activator of ARL3 GTPase

Basic information

Region (hg38): X:46837042-46882358

Links

ENSG00000102218NCBI:6102OMIM:300757HGNC:10274Uniprot:O75695AlphaFoldGenCCjaxSfariGnomADPubmed

Phenotypes

GenCC

Source: genCC

  • retinitis pigmentosa 2 (Strong), mode of inheritance: XL
  • retinitis pigmentosa (Supportive), mode of inheritance: AD
  • RP2-related retinopathy (Definitive), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Retinitis pigmentosa 2XLGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingOphthalmologic9697692; 10053026; 10942419; 11462235; 12417528; 20021257; 20625056; 21738648

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RP2 gene.

  • not provided (227 variants)
  • Retinitis pigmentosa (56 variants)
  • Retinitis pigmentosa 2 (32 variants)
  • Retinal dystrophy (21 variants)
  • Retinitis pigmentosa 3 (10 variants)
  • not specified (5 variants)
  • Inborn genetic diseases (5 variants)
  • Leber congenital amaurosis (3 variants)
  • X-linked retinitis pigmentosa (2 variants)
  • Macular dystrophy (1 variants)
  • Abnormality of the eye (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RP2 gene is commonly pathogenic or not.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous 1 1 11 7 20
missense 3 6 92 12 12 125
nonsense 26 4 30
start loss 0
frameshift 54 9 63
inframe indel 3 3 6
splice variant 5 7 5 17
non coding 1 2 5 4 12
Total 89 30 103 28 23

Variants in RP2

This is a list of pathogenic ClinVar variants found in the RP2 region.

Position Type Phenotype Significance ClinVar
X-46837057-G-C Retinitis pigmentosa Likely benign (Jan 13, 2018)link
X-46837066-A-G Retinitis pigmentosa Uncertain significance (Jan 13, 2018)link
X-46837075-G-T Retinitis pigmentosa Uncertain significance (Jan 12, 2018)link
X-46837089-CGGGCTGGGACCAT-C Pathogenic (Dec 09, 2020)link
X-46837101-A-G Pathogenic (Aug 09, 2022)link
X-46837101-A-T Pathogenic (Feb 14, 2022)link
X-46837102-T-A Pathogenic (Aug 28, 2021)link
X-46837102-T-C Retinitis pigmentosa • X-linked retinitis pigmentosa Pathogenic (Jul 12, 2022)link
X-46837102-T-G Pathogenic (May 29, 2022)link
X-46837104-G-A Uncertain significance (May 27, 2022)link
X-46837104-G-T Uncertain significance (May 06, 2022)link
X-46837108-G-C Retinitis pigmentosa 2 Conflicting interpretations of pathogenicity (Nov 01, 2022)link
X-46837108-GCTT-G Macular dystrophy • Retinal dystrophy • Cone-rod dystrophy Conflicting interpretations of pathogenicity (Jul 24, 2023)link
X-46837111-T-G Retinitis pigmentosa Conflicting interpretations of pathogenicity (Jul 19, 2022)link
X-46837111-TC-AA Pathogenic (Sep 24, 2021)link
X-46837114-TCTC-T Retinitis pigmentosa 2 • Retinitis pigmentosa Likely pathogenic (Jun 13, 2022)link
X-46837118-CAA-C Pathogenic (Jul 19, 2022)link
X-46837119-A-C Retinal dystrophy Uncertain significance (Jul 28, 2021)link
X-46837122-A-T Pathogenic (Aug 23, 2021)link
X-46837122-AGACG-A Retinitis pigmentosa Pathogenic (Jun 23, 2019)link
X-46837125-CGGAAGGCTGACAA-C Pathogenic (Dec 18, 2021)link
X-46837128-A-G Uncertain significance (Jun 30, 2021)link
X-46837130-G-A Retinitis pigmentosa Conflicting interpretations of pathogenicity (Nov 01, 2022)link
X-46837137-A-T Retinal dystrophy Likely pathogenic (Dec 31, 2018)link
X-46837138-A-T Retinal dystrophy Uncertain significance (Mar 27, 2019)link

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RP2protein_codingprotein_codingENST00000218340 545419
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9560.0439123595011235960.00000405
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6331121330.8450.000009872330
Missense in Polyphen1029.6080.33774502
Synonymous0.9324048.20.8290.00000361650
Loss of Function2.9009.790.006.92e-7179

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.00005420.0000341
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a GTPase-activating protein (GAP) involved in trafficking between the Golgi and the ciliary membrane. Involved in localization of proteins, such as NPHP3, to the cilium membrane by inducing hydrolysis of GTP ARL3, leading to the release of UNC119 (or UNC119B). Acts as a GTPase-activating protein (GAP) for tubulin in concert with tubulin-specific chaperone C, but does not enhance tubulin heterodimerization. Acts as guanine nucleotide dissociation inhibitor towards ADP-ribosylation factor-like proteins. {ECO:0000269|PubMed:11847227, ECO:0000269|PubMed:18376416, ECO:0000269|PubMed:20106869, ECO:0000269|PubMed:22085962}.;
Disease
DISEASE: Retinitis pigmentosa 2 (RP2) [MIM:312600]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10090907, ECO:0000269|PubMed:10520237, ECO:0000269|PubMed:10634633, ECO:0000269|PubMed:10937588, ECO:0000269|PubMed:10942419, ECO:0000269|PubMed:11462235, ECO:0000269|PubMed:11847227, ECO:0000269|PubMed:11992260, ECO:0000269|PubMed:12657579, ECO:0000269|PubMed:14564670, ECO:0000269|PubMed:16472755, ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:9697692}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Trafficking of myristoylated proteins to the cilium;Cargo trafficking to the periciliary membrane;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Recessive Scores

pRec
0.288

Intolerance Scores

loftool
0.122
rvis_EVS
0.35
rvis_percentile_EVS
74.18

Haploinsufficiency Scores

pHI
0.156
hipred
Y
hipred_score
0.547
ghis
0.522

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.569

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rp2
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;

Zebrafish Information Network

Gene name
rp2
Affected structure
retinal rod cell
Phenotype tag
abnormal
Phenotype quality
degeneration

Gene ontology

Biological process
cell morphogenesis;protein folding;post-Golgi vesicle-mediated transport;post-chaperonin tubulin folding pathway;visual perception;protein transport;positive regulation of GTPase activity
Cellular component
nucleoplasm;cytoplasm;Golgi apparatus;centriole;plasma membrane;cilium;nuclear body;cytoplasmic vesicle;ciliary basal body;extracellular exosome;periciliary membrane compartment
Molecular function
magnesium ion binding;GTPase activator activity;protein binding;GTP binding;unfolded protein binding